Macrophages are abundant in the uterine stroma and are intimately juxtaposed with other cell lineages comprising the uterine epithelial and stromal compartments. We postulated that macrophages may participate in mediating or amplifying the effects of ovarian steroid hormones to facilitate the uterine remodeling that is a characteristic feature of every estrus cycle and is essential for pregnancy. Using the Cd11b-Dtr transgenic mouse model with an ovariectomy and hormone replacement strategy, we depleted macrophages to determine their role in hormone-driven proliferation of uterine epithelial and stromal cells and uterine vascular development. Following diphtheria toxin (DT) administration, approximately 85% of EMR1-positive (EMR1 + ) macrophages, as well as 70% of CD11C + dendritic cells, were depleted from Cd11b-Dtr mice. There was no change in bromodeoxyuridine incorporation into epithelial cells induced to proliferate by administration of 17beta-estradiol (E2) to ovariectomized mice or into stromal cells induced to proliferate in response to E2 and progesterone (P4), and the resulting sizes and structures of the luminal epithelial and stromal cell compartments were not altered compared with those of leukocyte replete controls. Depletion of CD11B + myeloid cells failed to alter the density or pattern of distribution of uterine blood vessels, as identified by staining PECAM1-positive endothelial cells in the uterine stroma of E2-or E2 combined with P4 (E2P4)-treated ovariectomized mice. These experiments support the interpretation that macrophages are dispensable to regulation of proliferative events induced by steroid hormones in the cycling and early pregnant mouse uterus to establish the epithelial, stromal, and vascular architecture which is critical for normal reproductive competence.
INTRODUCTION
Over the course of each ovarian cycle, the uterus undergoes dynamic ovarian steroid hormone-regulated changes in cellular composition and structure in preparation for the possibility of embryo implantation [1] . In adult mice, 17b-estradiol (E2) induces a 4-fold increase in proliferation of luminal and glandular epithelial cells every estrus, which returns to baseline through apoptosis at diestrus, unless coitus occurs [2] . Following mating, progesterone (P4) suppresses epithelial cell proliferation and acts on the E2-primed uterus to enhance stromal cell proliferation and induce epithelial cell differentiation in preparation for embryo attachment and transmission of the decidualizing stimulus [3, 4] . Ovarian hormones regulate accompanying changes in the uterine vasculature, with an E2-induced increase in vascular permeability followed by a P4-induced induction of angiogenesis to expand the vascular supply required for implantation success [5] .
The effects of sex steroid hormones on target cells are at least partly mediated indirectly through paracrine or juxtacrine interactions with other cell types. Monoculture and coculture of murine uterine epithelial and stromal cells reveals that both cell compartments are required for E2-induced proliferation, and epithelium-stroma cell contact enhances this interaction [6] . Tissue recombination experiments using mice with a null mutation in the estrogen receptor gene Esr1 or the progesterone receptor gene Pgr indicate that steroid hormones exert effects on epithelial cells via an indirect mechanism mediated via cells located in the stromal compartment [7, 8] and imply a paracrine action of growth factors expressed in response to E2 [1, 9] .
Several growth factors secreted by uterine cells in response to E2, including IGF, Wnt, VEGF, and EGF family members, exert local control over epithelial and stromal cell proliferation [10] [11] [12] . Among the growth factors induced by E2 are hemopoietic cytokines and chemokines, which in turn direct the recruitment and activation of uterine leukocyte populations [13] [14] [15] . In the cycling mouse uterus, CSF1 (M-CSF) produced by epithelial cells in response to E2 is the paramount regulator of resident uterine macrophages [16] [17] [18] , the numbers of which peak in stromal tissues within the endometrium at proestrus, just prior to ovulation [9, 19, 20] . CSF1 acts in concert with CSF2 (GM-CSF) [20, 21] and chemokines including CCL2 (also known as MCP1), CCL3 (MIP1a), CCL4 (MIP1b), CXCL2 (MIP2), and CCL5 (RANTES) to orchestrate a complex pattern of resident macrophage phenotypes [15, 20] . After coitus, a surge in production of CSF2 and chemokines is responsible for a further recruitment of macrophages and their maturation into competent antigen-presenting cells within the preimplantation uterus [15, 20] . Additionally, uterine macrophages express the appropriate molecular machinery to respond directly to sex steroid hormones including estrogen receptor (ER) and progesterone receptor (PR) [22] , indicating that E2 and P4 may exert direct effects on the behavior of uterine macrophages [23, 24] .
Thus, macrophages respond to ovarian hormones over the course of the reproductive cycle and are positioned temporally and spatially to participate in cell proliferation and vascular remodeling during the estrous cycle and early pregnancy.
Macrophages can produce several growth factors and cytokines, in patterns that fluctuate according to their phenotype and activation status [23, 25] . These include IGF1, IGF2, and EGF, which induce proliferation and influence differentiation in epithelial cells and fibroblasts [26, 27] . Consistent with a paracrine action of uterine macrophages on neighboring epithelial cells, our recent studies have shown that macrophages can alter gene expression and attenuate the glycosylation phenotype in uterine epithelial cells through production of leukemia inhibitory factor (LIF), interleukin-1B, and other cytokines [28, 29] .
Macrophages also produce VEGF and other proangiogenic factors [30] and have the ability to influence both vascular permeability and angiogenesis [31] . VEGF is implicated in the remodeling of the uterine vasculature, which is essential for embryo implantation and establishing pregnancy [5] . VEGFproducing cells with a morphology and distribution similar to macrophages have been identified in the uterine stroma [32, 33] . Thus, macrophages potentially mediate the effects of E2 and P4 on uterine angiogenesis, and a contribution to this process would seem consistent with our recent finding that in the ovary, macrophages with a pro-angiogenic phenotype play essential roles in development of the corpus luteum vasculature in early pregnancy [34] .
Previous studies in female CSF1-deficient Csf1 op /Csf1 op mice reported fertility defects associated with uterine macrophage deficiency, but ovariectomy and hormone replacement experiments did not demonstrate any effect of CSF1 mutation on the capacity of uterine cells to undergo hormone-induced proliferation [17] . However, it is possible that the residual macrophages present in Csf1 op /Csf1 op tissues and/or a developmental adaptation to constitutive CSF1 absence influenced this result [16, 17] . Additionally, the impact of macrophage deficiency on the uterine vasculature was not evaluated. Thus, as an alternative approach to exploring the necessity for uterine macrophages in ovarian hormone-driven uterine tissue remodeling, we used transgenic mice expressing the diphtheria toxin receptor (Dtr) gene under direction of the Cd11b macrophage promoter (Cd11b-Dtr mice). This strategy allowed acute, transient depletion of most of the uterine EMR1-positive (EMR1 þ ) macrophages, as well as a substantial proportion of uterine CD11C þ dendritic cells (DC). The consequences of CD11B þ myeloid cell depletion in uterine cell proliferation and vascular development were investigated in ovariectomized mice treated with exogenous steroid hormones under conditions replicating estrus and early pregnancy. To alleviate the possibility of off-target effects of transgene expression, we used bone marrow chimeric mice expressing the Cd11b-Dtr transgene only in the hematopoietic compartment for most experiments.
MATERIALS AND METHODS

Mice and Surgical Treatments
Cd11b-Dtr mice on an FVB background (official symbol, Tg [Itgam-Dtr/ Egfp] 34Lan) were provided by Professor Richard Lang (University of Cincinnati). Colonies of Cd11b-Dtr and wild-type FVB mice were maintained by breeding homozygous pairs in a specific-pathogen-free facility at the University of Adelaide under controlled temperature and lighting (12L:12D) conditions. Food and water were supplied ad libitum. All experiments were performed in accordance with the Guiding Principles for the Care and Use of Research Animals endorsed by the Society for the Study of Reproduction, with approval from the University of Adelaide Animal Ethics Committee.
Transient acute depletion of CD11B þ myeloid cells was elicited by i.p. administration of 25 ng/g body weight diphtheria toxin (DT) from Corynebacterium diphtheria (Sigma). Two different experimental approaches were implemented in this study. In the first experiment, naturally cycling wildtype or Cd11b-Dtr females received DT at 0900 h during proestrus, as confirmed by daily vaginal smearing; then, 24 h later, vaginal smears were performed to confirm progression to the estrus stage. Mice were euthanized by cervical dislocation, and peritoneal exudate cells (PEC) and uteri were harvested for flow cytometric analysis or immunohistochemistry.
In the second experiment, wild-type FVB females were lethally irradiated with 900 cGy and then treated with donor bone marrow harvested from the tibia and fibula of female Cd11b-Dtr mice (5 3 10 6 cells i.v.; hereafter referred to as Cd11b-Dtr BM mice). Approximately 6 wk later, Cd11b-Dtr BM mice were ovariectomized through dorsal incision following avertin-induced anesthesia (Sigma). Following the procedure, mice received buprenorphine analgesia (0.8 lg/10 g of body weight, s.c.; Temgesic; Intervet, Schering-Plough). After a further 2-wk recovery period, ovariectomized mice were treated with ovarian steroid hormones as described previously [4] . Briefly, mice were primed for 2 consecutive days with 100 ng of E2 (Sigma), designated Day 1 and Day 2 of the treatment protocol, and then after another 6 days, mice were treated with either 50 ng of E2 (on Day 8 of the treatment protocol; E2-treated mice) or 1 mg of P4 for 4 days (Days 8-11) and 50 ng of E2 on Day 11 (E2 combined with P4 [E2P4]-treated mice). To induce CD11B þ myeloid cell depletion in E2-treated mice, DT (25 ng/g) was administered at 1200 h on Day 8 of the treatment protocol, while control E2-treated mice were given phosphatebuffered saline (PBS). To induce and sustain CD11B þ myeloid cell depletion over the course of the 4-day hormone treatment protocol in E2P4-treated mice, DT (25 ng/g of body weight) was administered at 1200 h on Day 7, Day 9, and Day 11 of the treatment protocol, while control E2P4-treated mice were given PBS. All mice received bromodeoxyuridine (BrdU; 1 mg in 100 ll of PBS) 13 h after the final hormone injection and were killed 2 h later on Day 9 (E2-treated mice) or Day 12 (E2P4-treated mice). PEC were collected to confirm CD11B þ myeloid cell depletion by flow cytometry, and uteri were collected and analyzed by immunohistochemistry.
Flow Cytometry
PEC were recovered by peritoneal lavage using 5 ml of ice cold PBS containing 0.1% bovine serum albumin and 0.025% sodium azide (a fluorescence-activated cell sorting [FACS] buffer). Uteri were dissected and trimmed of excess fat and then digested into a single-cell suspension by incubation for 1 h at 378C in RPMI medium containing 10% fetal bovine serum, 0.015 M HEPES, and 2000 U/ml type 1A collagenase from Clostridium histolyticum (Sigma) and 25 lg/ml DNase I (Sigma). Cells were passed through a 70-lm nylon strainer (BD Biosciences), and then washed and stained for flow cytometric analysis.
Fc receptors were blocked by resuspending cells in 50 ll of FACS buffer containing 0.5 lg of anti-Fc-cIIR antibody (FcBlock; BD Biosciences) for 10 min at 48C. Surface markers were labeled by adding 50 ll of FACS buffer containing 0.5 lg each of rat anti-mouse EMR1 Alexa-488 (which detects F4/ 80; BioLegend), CD11B APC, CD11C Alexa-488, CD3 fluorescein isothiocyanate, Ly6G/C PE-Cy5.5 (RB6-8C5 monoclonal antibody, which detects both Ly6 proteins), and CD45 PE-Cy7 (all, BD Biosciences) for 30 min at 48C. Data were analyzed using FACS Canto and FACS Diva software (BD Biosciences). Propidium iodide (0.8 lg/ml; Sigma) was added to labeled cell suspensions immediately prior to flow cytometry to enable exclusion of nonviable cells during analysis.
Immunohistochemistry
Uteri were collected from naturally cycling wild-type and Cd11b-Dtr mice or from ovariectomized and hormone-treated Cd11b-Dtr BM mice. For paraffin sections, whole uteri were fixed in 4% paraformaldehyde in PBS overnight at 48C, then washed in PBS, and embedded in paraffin. Transverse sections (6 lm) were mounted on glass slides and blocked with 15% normal rabbit serum plus 15% normal mouse serum for 30 min. Slides were incubated at 48C overnight with rat anti-mouse EMR1 (1:100 dilution; Caltag Laboratories), followed by 40 min at room temperature with biotinylated rabbit anti-rat immunoglobulin G (IgG; 1:600 dilution; Vector Laboratories), and were detected with ABC Vectorstain Elite reagents (Vector Laboratories), 3,3 0 -diaminobezidine (DAB), and H 2 O 2 (SigmaFast DAB; Sigma). Tissue sections were counterstained with hematoxylin (Sigma). Images of stained sections were captured using a Photonics Nanozoomer (Hamamatsu). Proliferating cells were detected using the BrdU in situ detection kit (BD Pharmingen) containing a biotinylated anti-BrdU antibody according to the manufacturer's instructions.
Staining was quantified using video image analysis software (Video Pro; Leading Edge Software). The area of positive staining was calculated as the area of DAB staining expressed as a percentage of the total stained (hematoxylin þ DAB) area. A minimum of 2 nonserial sections were assessed for each sample, and 4-6 fields were analyzed per section. To determine the percentage of endogenous peroxidase-positive eosinophils, slides were stained with DAB and hematoxylin only. The value for DAB positivity was subtracted from the total positivity detected for EMR1 staining.
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To determine the percentage of proliferating epithelial cells, individual nuclei in uterine luminal epithelium were counted using Image J software (U.S. National Institutes of Health) cell counter function, where both BrdU þ proliferating cells and BrdU À nonproliferating cells were counted, and the percentage of proliferating stromal cells was calculated using ImmunoRatio software (Institute of Biomedical Technology, University of Tamperekjoil; http://imtmicroscope.uta.fi/immunoratio/). Endometrial area and lumen perimeter were calculated by the manual tracing of these regions on the section image using NDP View software (Hamamatsu).
For fresh frozen sections, uteri were embedded in OCT compound (TissueTek, Sakuta Fintek) and frozen in liquid nitrogen-cooled isopentane. Cryostat sections (6 lm) were mounted on glass slides and fixed in 96% ethanol (vol/ vol) for 10 min at 48C. For localization of macrophages and endothelial cells, sections were incubated with rat anti-mouse EMR1 AlexaFluor-488 (1:50 dilution; BioLegend) and PECAM1 AlexaFluor-647 (1:100 dilution; BioLegend), respectively. Additional leukocyte subsets were detected using supernatants of rat anti-mouse hybridomas reactive with CD11B (American Type Culture Collection [ATCC] TIB128; macrophages and neutrophils), CD5 (number TIB105; B cells; ATCC) and CD45 (number TIB-122; all leukocytes; ATCC), or purified monoclonal antibodies reactive with Ly6G/C (clone Ly6G-8C5: Ly6G þ neutrophils and a subset of Ly6C þ monocytes; BD Pharmingen) and CD3 (clone 1782; T cells; BD Pharmingen), followed by detection using rabbit anti-rat IgG AlexaFluor-488 (Invitrogen). CD11C-positive cells were detected using biotinylated anti-CD11C (1:100 dilution; BD Biosciences) followed by streptavidin AlexaFluor-594 (1:100 dilution). Sections were counterstained with 4 0 ,6 0 -diamino-2-phenylindole (DAPI; 300 nM for 15 min at room temperature; Vector Laboratories) and mounted under coverslips using fluorescent mounting medium (DAKO). Staining was visualized using a Radiance 2100 (Olympus) or C1 laser scanning confocal microscope (Nikon) and quantified with the Image J image analysis system (NIH). To quantify the staining intensity of stromal endothelial cells, the stromal area was defined for each section, and the mean grayscale value for endothelial staining was calculated for 4-6 tissue sections per uterus (2-6 fields per section).
Statistics and Data Analyses
Data were analyzed for normality of distribution by using the Shapiro-Wilk normality test in SPSS version 17.0 software (IBM Corp., Armonk, NY). Because many data sets were not normally distributed, all data was analyzed by Mann-Whitney U test to evaluate the effect of DT treatment. Differences between groups were considered statistically significant when P , 0.05.
RESULTS
Effect of DT Administration on Immune Cell Populations in Cd11b-Dtr Mice
Initially, we investigated the utility of the Cd11b-Dtr mouse as a model for depletion of uterine macrophages. DT was administered to cycling wild-type and Cd11b-Dtr mice at proestrus, and tissue was harvested 24 h later, at estrus. When uterine leukocytes were analyzed by immunohistochemistry, cells expressing the macrophage marker EMR1 were substantially reduced but not absent from sections from Cd11b-Dtr mice compared with wild-type mice after DT treatment (Fig. 1,  A 
and B). Many of the residual EMR1
þ cells in DT-treated Cd11b-Dtr mice were confirmed to be eosinophils on the basis of their endogenous peroxidase activity (Fig. 1, C and D) . When endogenous peroxidase þ eosinophils were quantified by image analysis and subtracted from total EMR1 staining, EMR1 þ macrophages were seen to be reduced by 85% in Cd11b-Dtr mice after DT treatment (P , 0.001) (Fig. 1E) . Uterine tissues recovered at 48 h and 72 h after DT treatment showed sustained depletion of EMR1þ macrophages for at least 48 h, with partial recovery of the macrophage population at 72 h (data not shown).
Comparable results were obtained by flow cytometry analysis. Cells expressing EMR1 (Fig. 1F) were reduced by 50% in the uterus following DT treatment in Cd11b-Dtr mice, compared to DT-treated wild-type mice (P ¼ 0.04) ( Fig. 2A) . This contrasted with a more substantial 92% depletion of EMR1 þ cells from the peritoneal cavity (P ¼ 0.01) (Figs. 1G and 2B). As expected, most EMR1 þ cells also expressed the macrophage marker CD11B (Fig. 1F) , and 70% fewer CD11B
þ cells were present in the uterus of Cd11b-Dtr mice following DT treatment (P ¼ 0.03) (Fig 2C) , compared with 93% depletion in the peritoneal cavity (P ¼ 0.02) (Figs. 1G and 2D).
Additional markers were evaluated by flow cytometry to investigate the identity of residual CD11B þ cells and to determine whether leukocyte populations other than macrophages are affected by DT administration in Cd11b-Dtr mice (Fig. 2) . CD11B is not restricted to macrophages and is also expressed by neutrophils. In both the uterus and particularly in the PEC, a proportion of CD11B þ cells was retained after DT treatment. The antibody RB6-8C5 detects Ly6G expressed by neutrophils and the monocyte marker Ly6C [35] , which in the uterus, marks recently recruited EMR1 þ monocyte/macrophages [36] . A substantial subset of the residual CD11B þ cells express Ly6G/C but not EMR1, typical of neutrophils (Supplemental Fig. S1, A and B; all Supplemental Data are available online at www.biolreprod.org). Uterine cells expressing Ly6G/C were not significantly reduced after DT treatment, and Ly6G/C þ cells were also unaffected in the PEC (Fig. 2, E  and F) .
Notably, following DT treatment in Cd11b-Dtr mice, cells expressing the dendritic cell marker CD11C were reduced by 71% in the uterus (P ¼ 0.04) (Fig. 2G ) and by 85% in PEC (P ¼ 0.03) (Fig. 2H ). CD3 staining indicated no change in T cells in either the uterus or PEC after DT administration (Fig. 2, I and J). Consistent with macrophages and dendritic cells comprising a large proportion of leukocytes in the uterus, expression of leukocyte common antigen CD45 was reduced by 71% in the uterus (P ¼ 0.01) (Fig. 2K) and by 83% in PEC (P ¼ 0.02) (Fig. 2L) .
Effect of DT Administration on Uterine Immune Cell Populations in Cd11b-Dtr BM Mice
Uterine tissue from wild-type and Cd11b-Dtr mice treated with DT at proestrus and recovered 24 h later was examined for effects of CD11B þ myeloid cell depletion on uterine epithelial and stromal compartments and structures. No overt effects of CD11B þ myeloid cell depletion on the number or size of endometrial glands, the epithelial lining of the endometrial lumen, or the thickness of the endometrial or myometrial layers, were observed (not shown).
To more precisely examine the role of macrophages in uterine tissue structure, we used a bone marrow chimera model, wherein wild-type FVB mice containing Cd11b-Dtr donorderived bone marrow cells were generated. This strategy was used two reasons: (1) to eliminate the possibility of any nonspecific transgene expression, because in chimeras only Cd11b-Dtr donor-derived bone marrow cells contain the Dtr transgene, whereas nonhemopoietic cell lineages do not contain the transgene [29] ; and (2) to allow repeated administration of DT in an effort to achieve longer duration and greater extent of CD11B þ myeloid cell depletion [37, 38] . As irradiation treatment prior to bone marrow replacement disrupts ovarian function, and even in intact mice the ovary requires macrophages for progesterone synthesis [34] , the effect of CD11B þ myeloid cell depletion on ovarian hormoneregulated events in the uterus could not be studied in naturally cycling mice. Therefore, bone marrow-replaced chimeric (Cd11b-Dtr BM) mice were ovariectomized 4-6 wk after bone marrow transplant and subsequently treated with exogenous steroid hormones, with DT or PBS treatment in the final phase before analysis, as detailed in Materials and Methods.
Cd11b-Dtr BM mice in the first group were primed with E2, treated further with E2 to induce uterine epithelial cell proliferation, and given PBS or DT 12 h prior to analysis (E2-treated mice). The sensitivity to DT-induced depletion of CD11B þ myeloid cells in E2-treated Cd11b-Dtr BM mice was confirmed by flow cytometric analysis of CD11B þ and MACROPHAGES AND UTERINE REMODELING 
EMR1
þ cells in PEC and by immunostaining of EMR1 in uterine sections. As expected, EMR1 þ and CD11B þ cells in the peritoneal cavity were depleted by 96% (P , 0.001) (Supplemental Fig. S2 , A-C), which was comparable to the extent of depletion seen in intact Cd11b-Dtr mice. Uterine sections stained to detect EMR1 (Fig. 3, A and C) or CD11B (Fig. 3, B and D) showed a substantial reduction in cells expressing these markers following DT treatment in Cd11b-Dtr BM mice, comparable with that seen in intact Cd11b-Dtr mice. EMR1 þ cells were 72% fewer in number (P ¼ 0.02) (Fig. 3E ) than in intact Cd11b-Dtr mice; endogenous peroxidase staining showed the residual EMR1 þ cells were mainly eosinophils (Supplemental Fig. S2, D and E) .
To assess whether other immune cells were changed following DT treatment of Cd11b-Dtr BM mice, uterine sections were stained with relevant antibodies, and marker expression was visualized using confocal microscopy. In accordance with flow cytometry data from intact Cd11b-Dtr mice, CD11C þ dendritic cells (Fig. 4 , A and E) appeared partially diminished in Cd11b-Dtr BM mice, whereas Ly6G/ C þ neutrophil/monocytes (Fig. 4 , B and F) and CD3 þ T cells (Fig. 4, C and G) showed a similar distribution, and CD45 þ cells (Fig. 4 , D and H) were substantially fewer in DT-treated mice than in PBS-treated Cd11b-Dtr BM mice.
Effect of CD11B
þ Myeloid Cell Depletion on Epithelial and Endothelial Cells in E2-treated Cd11b-Dtr BM Mice
To investigate the requirement for macrophages in the proliferative response of uterine epithelial cells, E2-treated ovariectomized Cd11b-Dtr BM mice were injected with DT to deplete CD11B þ myeloid cells or with PBS vehicle control. Two hours before analysis at the time of maximum epithelial cell proliferation [4] , mice were injected with BrdU to enable detection of proliferating cells. When BrdU was visualized by immunohistochemistry with anti-BrdU antibodies, no differences were seen in the extent of uterine epithelial cell proliferation following treatment with PBS (Fig. 5, A and B) or DT (Fig. 5, C and D) , and this was confirmed when BrdU þ epithelial cells were quantified (Fig. 5E) . Consistent with this, there were no differences between PBS-and DT-treated mice in the perimeter of the uterine lumen (Fig. 5F ).
To investigate blood vessels in the uterine stroma, PECAM1 and EMR1 were colocalized in sections to identify endothelial cells and macrophages respectively. In mice treated with PBS (Fig. 5, G and H) or DT (Fig. 5, I and J), the density of PECAM1 staining was not different following CD11B þ myeloid cell depletion (Fig. 5K) . Although some variability between the patterns of vascular structures is seen in the endometrium and myometrium of different mice, it is clear that no consistent deficit was induced by CD11B þ myeloid cell depletion (Supplemental Fig. S3 ). 
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Effect of CD11B
þ Myeloid Cell Depletion on Stromal and Endothelial Cell Parameters in E2P4-treated Cd11b-Dtr BM Mice Proliferation of the uterine stroma occurs in response to E2 and P4 acting in combination to induce uterine receptivity to embryo implantation during early pregnancy [39] . At this time, macrophages are found throughout the uterine stroma and their close proximity could allow a regulatory influence on proliferation of other stromal cell lineages. To assess this, ovariectomized Cd11b-Dtr BM mice were primed and treated with E2 and P4 in combination (E2P4 treatment). During the course of hormone treatment, mice were treated with PBS or DT on 3 occasions 48 h apart to induce sustained CD11B þ myeloid cell depletion over the course of the treatment period. Two hours before analysis, mice were injected with BrdU to enable later detection of proliferating cells.
When BrdU incorporation was visualized with anti-BrdU antibodies, no differences were seen in the extent of uterine stromal cell proliferation following treatment with PBS (Fig. 6 , A and B) or with DT (Fig. 6, C and D) . The percentages of proliferating cells were not different between control and CD11B þ myeloid cell-depleted mice (Fig. 6E) , and neither were there any differences in the area of endometrial stromal tissue following treatment with PBS or DT (Fig. 6F) .
To determine whether macrophages contribute to angiogenesis and expansion of the blood vasculature following E2P4 treatment, PECAM1 and EMR1 were colocalized in uterine sections from control (Fig. 6, G and H) and CD11B þ myeloid cell-depleted mice (Fig. 6, I and J). The density of PECAM1 staining was unchanged following CD11B þ myeloid cell depletion (Fig. 6K) . Again, no consistent change in the distribution pattern or complexity of blood vessel architecture was seen in any compartment of the uterus after DT treatment (Supplemental Fig. S4 ).
DISCUSSION
In this study, we assessed the potential contribution of macrophages to local mediation of the ovarian hormoneinduced proliferative events and vascular changes that are essential to prepare the uterus for embryo implantation and the decidual response. Despite a strong rationale pointing to a role for macrophages, this study suggests that macrophages are not required for E2-induced epithelial cell proliferation, E2-plus-P4-induced stromal cell proliferation or the development of the uterine vasculature initiated with E2 and further expanded under the influence of P4. This confirms and extends previous studies [17] , providing strong evidence that macrophages are unlikely to be crucial for ovarian steroid hormone regulation of uterine remodeling over the estrus cycle and in early pregnancy, at least in mice.
Epithelial cell proliferation in the uterus therefore contrasts with ovarian hormone-induced epithelial cell proliferation in the mammary gland, where macrophage depletion during alveolar development causes a reduction in ductal epithelial cell proliferation, implying a regulatory control pathway involving macrophage-derived factors [40] . These results also distinguish control of the uterine vasculature, at least in the nonpregnant and preimplantation phases, from that in the corpus luteum of the ovary, where experiments in Cd11b-Dtr mice show that endothelial cell proliferation in early pregnancy depends absolutely on macrophage support [34] . One possible explanation for this striking difference is the nature of the extremely rapid and extensive neovascularization required in the corpus luteum [34] compared with the less dramatic expansion of the established vasculature over several days in the preimplantation uterus.
The Cd11b-Dtr transgenic mouse model used herein was informative about the roles of macrophages in reproductive tissues, but there are strengths and weaknesses of this model. First, tissue-dependent variations in macrophage depletion were seen. A macrophage depletion of approximately 85% was routinely achieved in the uterus within 24 h in both intact Cd11b-Dtr and bone marrow chimeric Cd11b-Dtr BM mice. This raises the caveat that we cannot fully exclude a role for macrophages in regulating the epithelial, stromal, and vascular compartments of the uterus. It remains possible, although highly unlikely, that the residual cells are adequate to execute full functional activity.
A second important consideration is that leukocytes other than macrophages were depleted from the uterus of Cd11b-Dtr mice after DT administration. In particular, uterine DCs expressing CD11C were substantially reduced. This finding is consistent with that of other experiments indicating an interaction between CD11C
þ DCs and CD11B þ macrophages in the uterus [18, 41, 42] . The loss of CD11C þ cells is relevant in view of a previous study in Cd11c-Dtr mice showing that CD11C
þ DCs are required for the deciduomal response, potentially via effects on the decidual vascular response [43] . This challenges reconciliation with the current study and our earlier observation that oil-induced deciduomas can be readily induced in hormone-primed Cd11b-Dtr mice after DT administration, whereas implantation proceeds normally when sufficient progesterone is administered [34] . Impaired decidualization after depletion of CD11B þ myeloid cells from Cd11b-Dtr mice would have seemed likely, but this discrepancy might be explained by only partial loss of CD11C þ cells in the Cd11b-Dtr mice.
Although Ly6G/C þ cells presumed to include neutrophils were substantially fewer in the intact uterus compared with macrophages and DCs, they were partially but not significantly diminished after DT treatment. Although generally viewed as a neutrophil marker by virtue of its reactivity with Ly6G, the RB6-8C5 antibody also recognizes Ly6C, which is expressed by a subset of monocytes after recent release from the bone marrow [35] . Ly6C is expressed on monocytes upon recruitment into the pregnant uterus, but Ly6C þ monocytes are rare in the nonpregnant uterus [18, 36] . Previous studies report effects of macrophage depletion on dendritic cell and neutrophil populations in other tissues [44, 45] . The extent of neutrophil depletion is tissue specific and may reflect dependence of tissue-resident neutrophils on macrophage signals, as opposed to a DT-induced systemic neutropenia [44] . CD3 þ T cells were not affected, as they do not express CD11B and have no lineage relationship with macrophages.
A third important consideration is the relative timing between CD11B þ myeloid cell removal and E2 treatment to induce epithelial cell proliferation. In the E2 treatment group, E2 was administered 9 h after DT treatment, when Cd11b-Dtr macrophages are expected to be undergoing apoptosis as shown by elevated annexin V staining and propidium iodide uptake [44] . Full macrophage depletion is estimated to be complete by 12 h in the peritoneal cavity [44] . Accordingly, although unlikely, it seems possible that treatment protocols to obtain CD11B þ myeloid cell depletion earlier in relation to E2 administration might reveal a greater impact on uterine epithelial proliferation. In the E2P4 treatment protocol, to assess macrophage involvement in stromal cell proliferation, CD11B
þ myeloid cells were depleted 24 h before hormone treatment began, and this was maintained for 5 days prior to CARE ET AL. MACROPHAGES AND UTERINE REMODELING tissue collection, giving high confidence that maximum effects of DT-mediated macrophage depletion would be obtained.
A fourth limitation of all DT-mediated leukocyte depletion models is the possibility of off-target effects of DT toxicity in cells other than the target lineage, due to unintended expression of the Dtr transgene in irrelevant cell lineages [46] . A strength of our strategy was to use bone marrow chimeric mice to eliminate the possibility of nonspecific transgene expression, as only Cd11b-Dtr donor-derived bone marrow cells contain the DTR transgene, whereas nonhemopoietic cell lineages do not [29] . One consequence of this was the inability to investigate hormone-mediated tissue remodeling events in pregnancy, as irradiation treatment renders mice infertile.
The Cd11b-Dtr mouse model has advantages over other macrophage depletion strategies. Administration of clodronate liposomes achieves local macrophage depletion in tissues including the ovary [47] but is ineffective in the uterus, as liposomes do not infiltrate the luminal epithelial barrier. In macrophage-deficient Csf1 op /Csf1 op mice [48] , the proliferative responses to hormones of uterine epithelial cells and stromal compartments are not affected [17, 20] . The limitation of these mice is that CSF1 deficiency is constitutive, and thus, the possibility that phenotypes are influenced by developmental defects, such as perturbed feedback regulation of the hypothalamus [49] , cannot be excluded. Additionally, although macrophage deficiency is nearly complete in the cycling uterus due to the dependence of resident macrophages on E2-induced CSF1 expression [18] , uterine macrophages are present in the progesterone-dependent phase of early pregnancy when proinflammatory signals other than CSF1 cause EMR1 þ cells to attain 53% of the population in wild-type mice [15, 16, 20] . Previous studies in hormone-treated Csf1 op /Csf1 op mice did not confirm that macrophage deficiency is retained after E2P4 treatment or whether P4-induced signals such as CCR2 override CSF1 deficiency.
These experiments do not entirely rule out the contribution of macrophages to generating uterine receptivity in early pregnancy, and there are several possible roles beyond those investigated in the current study. Macrophages are implicated in regulation of the female immune response to the antigenic challenges of insemination of coitus and invading conceptusderived cells at embryo implantation. The immune-regulatory functions of macrophages and their capacity to promote immune tolerance versus immune defense are controlled by ovarian steroid hormones as well as by signals in seminal fluid and those emanating from the embryo. Ovarian hormones influence macrophages largely through indirect regulation by hormone-regulated cytokines and chemokines, but additionally, uterine macrophages express the appropriate molecular machinery to respond directly to sex steroid hormones including ER and PR [22] , and exposure to ovarian hormones in vitro is demonstrated to attenuate their function [24] . Compared to their E2-induced estrus phenotype, uterine macrophages respond to P4 during early pregnancy with increased expression of major histocompatibility complex class II, which enhances antigen presentation and phagocytic efficiency as well as increased sensitivity to lipopolysaccharide (reviewed in ref. [24] ).
The absence of any effect of macrophage removal on the E2-plus-P4-induced uterine neovascularization does not rule out a less overt regulatory effect of macrophages on endothelial cells and vessel formation. Although proangiogeneic macrophages are linked with mitogenic actions in endothelial cells, underpinning branching morphogenesis in fetal development and tumor growth [50] , there is no report of essential macrophage functions in any adult tissue other than the ovary, which is unmatched in the requirement for rapid vascular development to achieve immediate steroidogenic function [34] . Notwithstanding this, myeloid leukocytes including macrophages do have roles in fine-tuning vascular parameters in adult neovascularization [51] , and even in established vasculature, macrophages produce tumor necrosis factor and other cytokines that modulate vascular permeability and other aspects of endothelial cell function [31] .
These results are consistent with those of experiments showing that with adequate progesterone support, embryo implantation and progression to pregnancy can occur in Cd11b-Dtr mice depleted of macrophages during the preimplantation phase [34] . Absence of an essential role in the preimplantation phase does not preclude macrophage facilitation of embryo attachment and placental morphogenesis. We have previously reported that macrophages regulate uterine epithelial cell expression of glycosylated structures required for embryo attachment [29] , and other studies show that coculture with macrophages increases the adhesiveness of uterine epithelial cells for trophoblast spheroids [52] .
The current experiments do not resolve the question of the pathways by which uterine stromal cells control epithelial cell proliferation. It seems possible that stromal cells other than macrophages communicate with epithelial cells and release growth factors that drive their proliferation. Although tissue recombination experiments in Esr1 À/À mice strongly suggest that E2 induces uterine epithelial cell proliferation in a paracrine manner [7] , interpretation of this data is complicated by the use of tissues from immature mice. Embryonic development of organs, including the uterus, is commonly dependent on epithelium-stroma interactions, and tissues from adult mice presumably behave differently [1] . Experiments using heterotypic recombinants between mouse and human uterine cell types are consistent with less interdependence between compartments and instead suggest that epithelial ER is required for E2-induced proliferation [53, 54] .
These studies confirm previous observations in Csf1 op / Csf1 op mice that any contribution of macrophages to uterine biology, at least in the nonpregnant state, is inferior to their crucial role in the ovary [17] . Further studies will be required to determine whether and the extent to which macrophages are a determinant of fertility in women, where altered numbers and function of macrophages are associated with endometrial dysfunction in some forms of unexplained infertility [55, 56] .
